Specialty Pharmaceuticals for Hyperlipidemia--Impact on Insurance Premiums.

N Engl J Med

From the Duke Clinical Research Institute (K.A.S., S.D.R.) and the Duke Institute for Health Innovation (S.B.), Duke Translational Medicine Institute, and the Department of Medicine (K.A.S., S.D.R.), Duke University School of Medicine, Durham, NC.

Published: October 2015

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1509863DOI Listing

Publication Analysis

Top Keywords

specialty pharmaceuticals
4
pharmaceuticals hyperlipidemia--impact
4
hyperlipidemia--impact insurance
4
insurance premiums
4
specialty
1
hyperlipidemia--impact
1
insurance
1
premiums
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!